Home/Filings/4/0001193125-25-301019
4//SEC Filing

Clark David Michael 4

Accession 0001193125-25-301019

CIK 0001178879other

Filed

Nov 25, 7:00 PM ET

Accepted

Nov 26, 9:17 PM ET

Size

5.1 KB

Accession

0001193125-25-301019

Insider Transaction Report

Form 4
Period: 2025-11-24
Clark David Michael
Chief People Officer
Transactions
  • Sale

    Common Stock

    2025-11-24$10.10/sh25,643$258,933296,975 total
Footnotes (1)
  • [F1]This price is the weighted average price for the transactions reported on this line. The prices for the transactions reported on this line range from $10.00 to $10.32 inclusive. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Documents

1 file

Issuer

AMICUS THERAPEUTICS, INC.

CIK 0001178879

Entity typeother

Related Parties

1
  • filerCIK 0001755662

Filing Metadata

Form type
4
Filed
Nov 25, 7:00 PM ET
Accepted
Nov 26, 9:17 PM ET
Size
5.1 KB